Search Results
Oct 20, 2025, 07:25 ET PAN GLOBAL COMMENCES PHASE 2 DRILLING AT CÁRMENES GOLD DISCOVERY, NORTHERN SPAIN
numerous Providencia targets VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ -- Pan Global Resources Inc. ("Pan Global" or the "Company") (TSXV: PGZ) (OTCQB:
More news about: Pan Global Resources Inc.
Oct 20, 2025, 07:25 ET PAN GLOBAL COMMENCES PHASE 2 DRILLING AT CÁRMENES GOLD DISCOVERY, NORTHERN SPAIN
numerous Providencia targets VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - Pan Global Resources Inc. ("Pan Global" or the "Company") (TSXV: PGZ) (OTCQB:
More news about: Pan Global Resources Inc.
Oct 20, 2025, 07:00 ET GoldMining Reports Initial Drill Results and Confirms Multiple New Mineralized Targets across São Jorge Project, Brazil
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to report initial
More news about: GoldMining Inc.
Oct 20, 2025, 04:57 ET The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, breast cancer (BC), gastric cancer (GC), gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 20, 2025, 04:18 ET Pet Food Market to Reach $128.7 Billion in 2024 in short term and $226.53 Billion by 2034 Globally, at 6.1% CAGR: Allied Market Research
https://www.alliedmarketresearch.com/checkout-final/7624241b6ac5c2fa0cc5c4bc3b6e51f6 Major Challenges in Industry & Solutions:
More news about: Allied Market Research
Oct 20, 2025, 01:44 ET Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
ADC trastuzumab botidotin (also known as A166) trastuzumab botidotin versus trastuzumab emtansine (T-DM1) in HER2-positive unresectable or metastatic BC was presented as an oral report by Professor Xichun Hu from Fudan University Shanghai Cancer Center (Presentation # LBA24, Proffered paper session 1:
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 19, 2025, 22:01 ET Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
Company, is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, BC, GC, gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase I inhibitor
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 18, 2025, 15:29 ET Seaspan fortalece la eficiencia de su flota mediante modernizaciones y actualizaciones de sus buques
actualizaciones integrales de sus buques VANCOUVER, BC, 18 de octubre de 2025 /PRNewswire/ -- Seaspan se complace en facilitar una actualización sobre su programa SAVER
More news about: Seaspan Corporation
Oct 18, 2025, 10:42 ET Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
expression status, sac-TMT demonstrated promising efficacy in previously treated HR+/HER2- BC patients. As the first Phase III clinical trial focusing exclusively on an all-Chinese population with HR+/HER2- BC, the presentation of the OptiTROP-Breast02 study data at ESMO marks a significant breakthrough
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 17, 2025, 21:01 ET Seaspan steigert die Effizienz der Flotte durch umfassende Nachrüstung und Modernisierung von Schiffen
VANCOUVER, BC, 18. Oktober 2025 /PRNewswire/ -- Seaspan freut sich, ein Update zu seinem SAVER (Seaspan Action on Vessel Energy Reduction) Programm zu geben, das 2013 ins Leben gerufen
More news about: Seaspan Corporation
Oct 17, 2025, 20:17 ET Seaspan renforce l'efficacité de sa flotte en procédant à des rénovations et à des mises à niveau complètes de ses navires
VANCOUVER, BC, 18 octobre 2025 /PRNewswire/ -- Seaspan a le plaisir de faire le point sur son programme SAVER (Seaspan Action on Vessel Energy Reduction) lancé en 2013, pionnier d'un
More news about: Seaspan Corporation
Oct 17, 2025, 16:04 ET Seaspan Strengthens Fleet Efficiency through Comprehensive Vessel Retrofits and Upgrades
VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ -- Seaspan is pleased to provide an update on its SAVER (Seaspan Action on Vessel Energy Reduction) program launched in 2013, pioneering an
More news about: Seaspan Corporation
Oct 17, 2025, 15:22 ET Seaspan Strengthens Fleet Efficiency through Comprehensive Vessel Retrofits and Upgrades
VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ - Seaspan is pleased to provide an update on its SAVER (Seaspan Action on Vessel Energy Reduction) program launched in 2013, pioneering an
More news about: Seaspan Corporation
Oct 17, 2025, 09:50 ET Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
of GT Biopharma, Inc. VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ --
More news about: Equity Insider
Oct 17, 2025, 09:00 ET The Palace Museum Centennial: A Century of Guardianship and Legacy
entrusted with this mission. In 1933, he was assigned to escort some other antiques in a new batch — the ten Stone Drums of the Qin Dynasty (221-206 BC), revered as the "No.1 antiques of China," which were then housed at Guozijian, the Imperial Academy. The daunting task required painstaking efforts.
More news about: China.org.cn
Oct 17, 2025, 05:42 ET Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
broadly covering 2L+ HER2 BC patients, trastuzumab botidotin leverages its differentiated structural design to deliver superior efficacy while addressing unmet clinical needs in this population." About HER2+ BC
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 17, 2025, 05:00 ET Rebecca Rau Jewels Unveils the THEN & NOW Collection, a Fusion of Ancient Artifacts and Modern Adornment
a striking new series that bridges the worlds of antiquity and contemporary design. Drawing upon genuine historical artifacts spanning from 1200 BC to 1880 AD, each piece integrates ancient treasures with modern gemstones, precious metals, and pearls. Every jewel is a celebration of human history,
More news about: Rebecca Rau Jewels
Oct 17, 2025, 03:00 ET SIMAGIC at SimRacing Expo 2025: A Triple Reveal
Showcases Next-Generation Simulation at SimRacing Expo 2025 October 17–19, 2025 | Hall 3, Booth BC6 | Messe Dortmund, Germany DORTMUND, Germany,
More news about: SIMAGIC TECHNOLOGY CO., LIMITED
Oct 17, 2025, 03:00 ET SIMAGIC auf SimRacing Expo 2025: Eine Dreifach-Enthüllung
nächste Simulationsgeneration auf der SimRacing Expo 2025. 17.–19. Oktober 2025 | Halle 3, Stand BC6 | Messe Dortmund, Deutschland DORTMUND, Deutschland,
More news about: SIMAGIC TECHNOLOGY CO., LIMITED
Oct 17, 2025, 03:00 ET SIMAGIC at SimRacing Expo 2025: A Triple Reveal
Showcases Next-Generation Simulation at SimRacing Expo 2025 October 17–19, 2025 | Hall 3, Booth BC6 | Messe Dortmund, Germany DORTMUND, Germany,
More news about: SIMAGIC TECHNOLOGY CO., LIMITED
Oct 17, 2025, 03:00 ET SIMAGIC à SimRacing Expo 2025 : une triple révélation
présente la simulation de nouvelle génération à SimRacing Expo 2025 17-19 octobre 2025 | Hall 3, Stand BC6 | Messe Dortmund, Allemagne DORTMUND, Allemagne,
More news about: SIMAGIC TECHNOLOGY CO., LIMITED
Oct 17, 2025, 03:00 ET SIMAGIC en SimRacing Expo 2025: Triple revelación
SIMAGIC presenta simulación de última generación en SimRacing Expo 2025 17-19 de octubre de 2025 | Pabellón 3, Stand BC6 | Messe Dortmund, Alemania DORTMUND, Alemania,
More news about: SIMAGIC TECHNOLOGY CO., LIMITED
Oct 16, 2025, 18:35 ET Uranium Royalty Announces Voting Results
DESIGNATED NEWS RELEASE VANCOUVER, BC, Oct. 16, 2025 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company")
More news about: Uranium Royalty Corp.
Oct 16, 2025, 16:14 ET Texas Children's Hospital Nurse Morgan Fischer Recognized as 2025 National Magnet Nurse of the Year for Transformational Leadership
Jackie Ward, DNP, RN, NE-BC, System Chief Nurse Executive and Senior Vice President at Texas Children's. "She is a role model, a change agent and a true leader whose influence
More news about: Texas Children's Hospital
Oct 16, 2025, 16:05 ET INTEGRA PUBLISHES 5th ANNUAL SUSTAINABILITY REPORT
www.integraresources.com VANCOUVER, BC, Oct. 16, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American:
More news about: Integra Resources Corp.